Fred Cohen, M.D., D.Phil

Fred Cohen is a founder and member of the investment committee of Monograph Capital Partners, which he co-founded in 2021. Prior to Monograph, he was co-founder and senior managing director of Vida Ventures and managing partner at TPG Biotechnology, where he initiated TPG’s venture efforts in biotechnology and life sciences in 2001. Earlier, Fred was a professor at UCSF, where he served as chief of the division of endocrinology and metabolism and led research in prion biology, drug design, bioinformatics, and heteropolymer chemistry. He is a member of the National Academy of Medicine, the American Academy of Arts and Sciences, and a fellow of the American College of Physicians. He has received several awards, including the Burroughs-Wellcome New Initiatives in Malaria Award, the LVMH Science Pour L’Art Prize, and the Searle Scholars Award. Fred graduated magna cum laude from Yale University in 1978, received his D.Phil. from Oxford University as a Rhodes Scholar in 1980, earned his M.D. from Stanford Medical School as an American Cancer Society Postdoctoral Fellow in 1984 and completed his internal medicine and endocrinology training at UCSF.